Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

FLGT – Fulgent Genetics, Inc.

Float Short %

10.61

Margin Of Safety %

Put/Call OI Ratio

0.08

EPS Next Q Diff

0.03

EPS Last/This Y

1.06

EPS This/Next Y

-0.31

Price

21.69

Target Price

25.33

Analyst Recom

2

Performance Q

6.09

Relative Volume

0.69

Beta

0.79

Ticker: FLGT




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-25FLGT18.380.060.0513271
2025-07-28FLGT18.020.060.0113300
2025-07-29FLGT17.580.060.0013408
2025-07-30FLGT17.50.060.0113451
2025-07-31FLGT17.160.060.0413529
2025-08-01FLGT18.520.060.2515577
2025-08-04FLGT18.340.061.1115641
2025-08-05FLGT20.770.060.0515667
2025-08-06FLGT20.680.060.0315140
2025-08-07FLGT20.410.060.0315162
2025-08-08FLGT20.350.0737.3314930
2025-08-11FLGT20.610.070.3914963
2025-08-12FLGT20.980.070.2414971
2025-08-13FLGT21.760.070.0914941
2025-08-14FLGT21.760.070.0014750
2025-08-15FLGT21.250.070.0314736
2025-08-18FLGT21.490.080.0212214
2025-08-19FLGT21.590.080.0012281
2025-08-20FLGT21.380.086.0012282
2025-08-21FLGT21.380.082.0012286
2025-08-22FLGT21.730.080.0212286
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-25FLGT18.37-223.218.8-0.55
2025-07-28FLGT17.99-223.220.6-0.55
2025-07-29FLGT17.57-223.221.2-0.55
2025-07-30FLGT17.49-223.219.1-0.55
2025-07-31FLGT17.18-223.220.5-0.55
2025-08-01FLGT18.53-223.29.6-0.55
2025-08-04FLGT18.36-163.119.4-0.55
2025-08-05FLGT20.78-163.16.5-0.55
2025-08-06FLGT20.67-163.121.6-0.55
2025-08-07FLGT20.41-163.122.3-0.55
2025-08-08FLGT20.36-163.121.4-0.35
2025-08-11FLGT20.64-172.320.0-0.35
2025-08-12FLGT20.99-172.319.7-0.35
2025-08-13FLGT21.77-172.318.2-0.35
2025-08-14FLGT21.74-172.321.3-0.35
2025-08-15FLGT21.24-172.323.0-0.35
2025-08-18FLGT21.49-172.320.4-0.35
2025-08-19FLGT21.57-172.321.1-0.35
2025-08-20FLGT21.35-172.322.0-0.35
2025-08-21FLGT21.37-172.321.3-0.35
2025-08-22FLGT21.69-172.320.2-0.35
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-25FLGT0.89-12.169.50
2025-07-28FLGT0.89-13.349.50
2025-07-29FLGT0.89-13.349.50
2025-07-30FLGT0.89-13.349.50
2025-07-31FLGT0.89-13.349.50
2025-08-01FLGT0.89-13.349.50
2025-08-04FLGT0.89-13.479.50
2025-08-05FLGT0.89-13.479.50
2025-08-06FLGT0.88-13.479.45
2025-08-07FLGT0.88-13.479.45
2025-08-08FLGT0.88-13.479.45
2025-08-11FLGT0.88-17.079.45
2025-08-12FLGT0.88-17.0710.61
2025-08-13FLGT0.88-17.0710.61
2025-08-14FLGT0.88-17.0710.61
2025-08-15FLGT0.88-17.0710.61
2025-08-18FLGT0.88-15.3510.61
2025-08-19FLGT0.88-15.3510.61
2025-08-20FLGT0.88-15.3510.61
2025-08-21FLGT0.88-15.3510.61
2025-08-22FLGT0.88-15.3510.61
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-0.25

Avg. EPS Est. Current Quarter

-0.22

Avg. EPS Est. Next Quarter

-0.22

Insider Transactions

0.88

Institutional Transactions

-15.35

Beta

0.79

Average Sales Estimate Current Quarter

81

Average Sales Estimate Next Quarter

83

Fair Value

Quality Score

41

Growth Score

36

Sentiment Score

47

Actual DrawDown %

88.6

Max Drawdown 5-Year %

-91.7

Target Price

25.33

P/E

Forward P/E

PEG

P/S

2.2

P/B

0.6

P/Free Cash Flow

EPS

-1.67

Average EPS Est. Cur. Y​

-0.35

EPS Next Y. (Est.)

-0.66

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-16.83

Relative Volume

0.69

Return on Equity vs Sector %

-29.3

Return on Equity vs Industry %

-15.3

EPS 1 7Days Diff

0.2

EPS 1 30Days Diff

0.2

EBIT Estimation

20.2
Fulgent Genetics, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 1313
Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. The company was founded in 2011 and is headquartered in El Monte, California.
stock quote shares FLGT – Fulgent Genetics, Inc. Stock Price stock today
news today FLGT – Fulgent Genetics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch FLGT – Fulgent Genetics, Inc. yahoo finance google finance
stock history FLGT – Fulgent Genetics, Inc. invest stock market
stock prices FLGT premarket after hours
ticker FLGT fair value insiders trading